[
    [
        {
            "time": "",
            "original_text": "恒瑞为什么是第一？“创新100强”四梯级榜单公布，TOP10药企临床试验占据中国半壁江山！",
            "features": {
                "keywords": [
                    "恒瑞",
                    "创新100强",
                    "四梯级榜单",
                    "TOP10药企",
                    "临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "恒瑞为什么是第一？“创新100强”四梯级榜单公布，TOP10药企临床试验占据中国半壁江山！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "贝达药业主力产品正式进入优先审评程序 新药研发进展缓慢",
            "features": {
                "keywords": [
                    "贝达药业",
                    "主力产品",
                    "优先审评",
                    "新药研发",
                    "进展缓慢"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝达药业主力产品正式进入优先审评程序 新药研发进展缓慢",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "融资客青睐13股，海越能源买入占比高达48.17%",
            "features": {
                "keywords": [
                    "融资客",
                    "海越能源",
                    "买入占比",
                    "48.17%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "融资客青睐13股，海越能源买入占比高达48.17%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]